MSIF news | 09 October 2013
The new Atlas of MS 2013 – the most extensive worldwide study of multiple sclerosis – was launched to the MS research community at ECTRIMS in Copenhagen on Friday 4 October.
MSIF news | 19 September 2013
The Progressive MS Alliance is calling on researchers to submit proposals for research into progressive MS. Proposals must be submitted by 14 January 2014.
MSIF news | 17 September 2013
The Atlas of MS 2013, the most extensive worldwide study of the disease, is due to be launched on 4 October. Find out why the Atlas has been updated
News from MS organisations | 09 September 2013
UK MS Society Trustee Stuart Nixon is taking on a challenge to mark the Society's 60th birthday. Between 5 and 13 October, Stuart will be walking the Jubilee Greenway, a 60km walk from Buckingham Palace to the Olympic Park and back.
MSIF news | 05 August 2013
The summary report of World MS Day 2013 is now available for download.
We will be sending a more comprehensive evaluation report to our members and affiliated organisations later this week.
MSIF news | 10 July 2013
The third issue of Tawasol, the e-newsletter for MS organisations in the Arabic-speaking region, is now available for download. The newsletter, which is co-ordinated and edited by MSIF, aims to keep the Arabic-speaking world up to date on the activities in the region.
MSIF news | 05 July 2013
A two-year country-focused capacity building programme was launched by MSIF this year targeting three MS organisations from the Arab region: the Lebanese MS Friends Society (ALSEP), MS Care Egypt and Multiple Sclerosis Patients Friends - Palestine (MSPF).
MSIF news | 04 July 2013
We're delighted to announce that Maurice Maso from Belgium is the winner of the 2013 Evelyn Nicholson Award for International Caregiver.
MSIF news | 20 June 2013
Dr Suresh Menon from India, who was awarded a MSIF McDonald Fellowship award in 2010 to undertake a two-year fellowship at the UBC Faculty of Medicine in Vancouver, Canada, has published results from the work he did on aggressive types of MS.
News from MS organisations | 11 June 2013
A small, exploratory/feasibility trial in just 10 patients has shown that a new therapy for MS that teaches the immune system to recognise and ignore its own nerve tissue, appears to be safe and well tolerated in humans.